Almac Group has announced the official opening of new GMP-qualified analytical stability chambers and office space at its US Headquarter campus in Souderton, Pennsylvania.
Eramol, a UK-based pharmaceutical contract development and manufacturing organisation (CDMO), has announced progress on its new sterile manufacturing facility, scheduled to open in early 2026.
Centauri, an immunotherapy company, announced that CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) has provided an additional $5.1M in funding for the development of their lead compound.
Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova virus removal filters in Nobeoka City, Miyazaki, Japan.
Kling Bio has entered into a collaboration and license option agreement with Sanofi for the discovery of antibodies and epitopes using its B cell immortalisation and screening platform, Kling-Select.
Neuraxpharm announces the launch of a new affiliate, Neuraxpharm Australia, led by newly appointed head of commercial, Avendran Naidu, as the Company continues to expand globally.
Vicebio, a biopharmaceutical company developing vaccines against life-threatening respiratory viral infections, has entered an exclusive, definitive agreement to be acquired by Sanofi.
Aenova, a global contract development and manufacturing organisation (CDMO), is expanding its site in Killorglin with a spray drying platform for amorphous solid dispersions (ASD) and inhalation powders.
Ampersand Capital Partners, a private equity firm specialising in growth equity investments in the life sciences and healthcare sectors, has announced the acquisition of CurTec.
West Pharmaceutical Services, a specialist in innovative solutions for injectable drug administration, announced that it opened a new purpose-built analytical laboratory building near its manufacturing site in Stolberg.
